Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

von Willebrand Factor in Pregnancy (VIP) Study: A Multicenter Study of Wilate Use in von Willebrand Disease for Childbirth

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Wheeler, Allison

NCTID:

Protocol No: VICCNCBH2005

A Phase 2 Study of Dabrafenib (NSC# 763760) with Trametinib (NSC# 763093) after Local Irradiation in Newly-Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG) (IND# 145355)

Multiple Cancer Types

Disease Sites: Neuro-Oncology, Pediatrics

Phase: II

Investigator: Pastakia, Devang

NCTID: NCT03919071

Protocol No: COGACNS1723

Prospective Validation of a Venous Thrombosis Risk Assessment Model in Critically Ill Children from the CHAT Registry

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Wheeler, Allison

NCTID:

Protocol No: VICCNCBH2010

COLOMATE: COlorectal Cancer Liquid BiOpsy Screening Protocol for Molecularly Assigned ThErapy

Multiple Cancer Types

Disease Sites: Colon, Rectal

Phase: N/A

Investigator: Ciombor, Kristen

NCTID: NCT03765736

Protocol No: VICCGI2011

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Nave Patients with Mayo Stage IIIa AL Amyloidosis

Hematologic

Disease Sites: Hematologic

Phase: III

Investigator: Sengsayadeth, Salyka

NCTID: NCT04512235

Protocol No: VICCPCL2080

Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment in Breast Cancer

Breast

Disease Sites: Breast

Phase: N/A

Investigator: Kennedy, Laura

NCTID: NCT04803084

Protocol No: VICCBRE20104

A Phase 1/2 Study of ALX148 in Combination with Azacitidine in Patients with Higher Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

Disease Sites: Myelodysplastic Syndrome

Phase: I/II

Investigator: Kishtagari, Ashwin

NCTID: NCT04417517

Protocol No: VICCHEMP2084

An Open-Label, Multicenter, Randomized Phase 3 Study of First-Line Encorafenib Plus Cetuximab with or without Chemotherapy versus Standard of Care Therapy with a Safety Lead-In of Encorafenib and Cetuximab Plus Chemotherapy In Participants with Metastatic BRAF V600e-Mutant Colorectal Cancer

Multiple Cancer Types

Disease Sites: Colon, Rectal

Phase: III

Investigator: Eng, Cathy

NCTID: NCT04607421

Protocol No: VICCGI2085

A Multicenter Phase Ib Trial for Patients with Advanced Hematologic Malignancies undergoing Allogeneic Hematopoietic Cell Transplantation with TregGraft, a T-cell-Depleted Graft with Additional Infusion of Conventional T cells and Regulatory T cells

Multiple Cancer Types

Disease Sites: Leukemia, Myelodysplastic Syndrome, Phase I

Phase: I

Investigator: Dholaria, Bhagirathbhai

NCTID: NCT04013685

Protocol No: VICCCTTP2086

JHMIRB: Prospective Clinical Study of the Relationship Between Cancer Driving Mutations Found in Endometriotic Implants and Development of Progesterone Resistance

Gynecologic

Disease Sites: Gynecologic

Phase: N/A

Investigator: Tran, Kaylon

NCTID:

Protocol No: VICCGYN2091

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)